Loading...

KALA KALA BIO INC Management Changes 8-K Filing

KL B

KL

KALA BIO INC

(KALA)

2025 8-K

Show Summary

Summary

Product Expansion

Executive Retention

Financial Results

CEO Resignation

Financial Results

Director Resignation

Earnings Reports

Securities Purchase Agreement

Annual Meeting Results

Financial Results Announcement

Financial Results Announcement

Securities Purchase Agreement

Presentation and Clinical T...

Securities Purchase Agreement

Financial Results Announcement

Financial Results

Departure of Directors or C...

Financial Results Announcement

Meeting Results

Clinical Trial Results

Financial Results Announcement

Open Market Sale Agreement

Listing Transfer Approval

External Links:

On April 10, 2025, KALA BIO, Inc. signed retention agreements with key executives, including bonuses of $281,190 for Todd Bazemore, $234,000 for Mary Reumuth, and $260,000 for Kim Brazzell, contingent on their employment status until September 30, 2025 or the announcement of clinical trial data.

AI Assistant

KALA BIO INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.